{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:42:16Z","timestamp":1772264536523,"version":"3.50.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEOII\/2015\/021"],"award-info":[{"award-number":["PROMETEOII\/2015\/021"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006751","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Salud Mental","doi-asserted-by":"publisher","award":["Intramural 2015"],"award-info":[{"award-number":["Intramural 2015"]}],"id":[{"id":"10.13039\/501100006751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13643-017-0466-y","type":"journal-article","created":{"date-parts":[[2017,4,4]],"date-time":"2017-04-04T08:50:37Z","timestamp":1491295837000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies"],"prefix":"10.1186","volume":"6","author":[{"given":"Ferr\u00e1n","family":"Catal\u00e1-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Hutton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane A.","family":"Driver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Ridao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Valderas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo","family":"Alonso-Arroyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"For\u00e9s-Martos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricard","family":"G\u00e8nova-Maleras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Mac\u00edas-Saint-Gerons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedicto","family":"Crespo-Facorro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Vieta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Tabar\u00e9s-Seisdedos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,4]]},"reference":[{"key":"466_CR1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"GBD 2015 Mortality and Causes of Death Collaborators","year":"2016","unstructured":"GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459\u2013544.","journal-title":"Lancet"},{"key":"466_CR2","doi-asserted-by":"publisher","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; Published online December 3, 2016. doi: 10.1001\/jamaoncol.2016.5688","DOI":"10.1001\/jamaoncol.2016.5688"},{"key":"466_CR3","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.euroneuro.2013.04.001","volume":"23","author":"F Catal\u00e1-L\u00f3pez","year":"2013","unstructured":"Catal\u00e1-L\u00f3pez F, G\u00e8nova-Maleras R, Vieta E, Tabar\u00e9s-Seisdedos R. The increasing burden of mental and neurological disorders. Eur Neuropsychopharmacol. 2013;23:1337\u20139.","journal-title":"Eur Neuropsychopharmacol"},{"key":"466_CR4","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(16)31678-6","volume":"388","author":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators","year":"2016","unstructured":"GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545\u2013602.","journal-title":"Lancet"},{"key":"466_CR5","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","volume":"388","author":"GBD 2015 DALYs and HALE Collaborators","year":"2016","unstructured":"GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1603\u201358.","journal-title":"Lancet"},{"key":"466_CR6","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(14)62254-6","volume":"386","author":"R Atun","year":"2015","unstructured":"Atun R. Transitioning health systems for multimorbidity. Lancet. 2015;386:721\u20132.","journal-title":"Lancet"},{"key":"466_CR7","doi-asserted-by":"crossref","first-page":"h176","DOI":"10.1136\/bmj.h176","volume":"350","author":"E Wallace","year":"2015","unstructured":"Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350:h176.","journal-title":"BMJ"},{"key":"466_CR8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37\u201343.","journal-title":"Lancet"},{"key":"466_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.bjc.6602279","volume":"92","author":"JH Olsen","year":"2005","unstructured":"Olsen JH, Friis S, Frederiksen K, McLaughlin JK, Mellemkjaer L. Moller H-Atypical cancer pattern in patients with Parkinson\u2019s disease. Br J Cancer. 2005;92:201\u20135.","journal-title":"Br J Cancer"},{"key":"466_CR10","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/ijc.27443","volume":"131","author":"K Rugbjerg","year":"2012","unstructured":"Rugbjerg K, Friis S, Lassen CF, Ritz B, Olsen JH. Malignant melanoma, breast cancer and other cancers in patients with Parkinson\u2019s disease. Int J Cancer. 2012;131:1904\u201311.","journal-title":"Int J Cancer"},{"key":"466_CR11","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/01.wnl.0000345366.10455.62","volume":"72","author":"S Bahmanyar","year":"2009","unstructured":"Bahmanyar S, Montgomery SM, Hillert J, Ekbom A, Olsson T. Cancer risk among patients with multiple sclerosis and their parents. Neurology. 2009;72:1170\u20137.","journal-title":"Neurology"},{"key":"466_CR12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/jnnp.2009.175463","volume":"81","author":"AF Fois","year":"2010","unstructured":"Fois AF, Wotton CJ, Yeates D, Turner MR, Goldacre MJ. Cancer in patients with motor neuron disease, multiple sclerosis and Parkinson\u2019s disease: record linkage studies. J Neurol Neurosurg Psychiatry. 2010;81:215\u201321.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"466_CR13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2008.01163.x","volume":"117","author":"VS Catts","year":"2008","unstructured":"Catts VS, Catts SV, O\u2019Toole BI, Frost AD. Cancer incidence in patients with schizophrenia and their first-degree relatives\u2014a meta-analysis. Acta Psychiatr Scand. 2008;117:323\u201336.","journal-title":"Acta Psychiatr Scand"},{"key":"466_CR14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.schres.2009.07.012","volume":"114","author":"CJ Bushe","year":"2009","unstructured":"Bushe CJ, Bradley AJ, Wildgust HJ, Hodgson RE. Schizophrenia and breast cancer incidence: a systematic review of clinical studies. Schizophr Res. 2009;114:6\u201316.","journal-title":"Schizophr Res"},{"key":"466_CR15","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1212\/WNL.0b013e31821e554e","volume":"76","author":"R Liu","year":"2011","unstructured":"Liu R, Gao X, Lu Y, Chen H. Meta-analysis of the relationship between Parkinson disease and melanoma. Neurology. 2011;76:2002\u20139.","journal-title":"Neurology"},{"key":"466_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000356498","volume":"83","author":"F Catal\u00e1-L\u00f3pez","year":"2014","unstructured":"Catal\u00e1-L\u00f3pez F, Su\u00e1rez-Pinilla M, Su\u00e1rez-Pinilla P, Valderas JM, G\u00f3mez-Beneyto M, Mart\u00ednez S, et al. Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom. 2014;83:89\u2013105.","journal-title":"Psychother Psychosom"},{"key":"466_CR17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S1470-2045(11)70041-9","volume":"12","author":"R Tabar\u00e9s-Seisdedos","year":"2011","unstructured":"Tabar\u00e9s-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, et al. No paradox, no progress: inverse cancer comorbidity in people with other complex diseases. Lancet Oncol. 2011;12:604\u20138.","journal-title":"Lancet Oncol"},{"key":"466_CR18","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1212\/01.WNL.0000152889.94785.51","volume":"64","author":"CM Roe","year":"2005","unstructured":"Roe CM, Behrens MI, Xiong C, Miller JP, Morris JC. Alzheimer disease and cancer. Neurology. 2005;64:895\u20138.","journal-title":"Neurology"},{"key":"466_CR19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1212\/WNL.0b013e3181c91873","volume":"74","author":"CM Roe","year":"2010","unstructured":"Roe CM, Fitzpatrick AL, Xiong C, Sieh W, Kuller L, Miller JP, et al. Cancer linked to Alzheimer disease but not vascular dementia. Neurology. 2010;74:106\u201312.","journal-title":"Neurology"},{"key":"466_CR20","doi-asserted-by":"crossref","first-page":"e1442","DOI":"10.1136\/bmj.e1442","volume":"344","author":"JA Driver","year":"2012","unstructured":"Driver JA, Beiser A, Au R, Kreger BE, Splansky GL, Kurth T, et al. Inverse association between cancer and Alzheimer\u2019s disease: results from the Framingham Heart Study. BMJ. 2012;344:e1442.","journal-title":"BMJ"},{"key":"466_CR21","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1212\/WNL.0b013e31829c5ec1","volume":"81","author":"M Musicco","year":"2013","unstructured":"Musicco M, Adorni F, Di Santo S, Prinelli F, Pettenati C, Caltagirone C, et al. Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study. Neurology. 2013;81:322\u20138.","journal-title":"Neurology"},{"key":"466_CR22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000355899","volume":"42","author":"F Catal\u00e1-L\u00f3pez","year":"2014","unstructured":"Catal\u00e1-L\u00f3pez F, Crespo-Facorro B, Vieta E, Valderas JM, Valencia A, Tabar\u00e9s-Seisdedos R. Alzheimer\u2019s disease and cancer: current epidemiological evidence for a mutual protection. Neuroepidemiology. 2014;42:121\u20132.","journal-title":"Neuroepidemiology"},{"key":"466_CR23","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s10072-015-2282-2","volume":"36","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Guo S, Zhang X, Tang S, Shao W, Han X, Wang L, Du Y. Inverse relationship between cancer and Alzheimer\u2019s disease: a systemic review meta-analysis. Neurol Sci. 2015;36:1987\u201394.","journal-title":"Neurol Sci"},{"key":"466_CR24","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1055-9965.EPI-07-0038","volume":"16","author":"JA Driver","year":"2007","unstructured":"Driver JA, Logroscino G, Buring JE, Gaziano JM, Kurth T. A prospective cohort study of cancer incidence following the diagnosis of Parkinson\u2019s disease. Cancer Epidemiol Biomarkers Prev. 2007;16:1260\u20135.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"466_CR25","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/mds.20401","volume":"20","author":"A Elbaz","year":"2005","unstructured":"Elbaz A, Peterson BJ, Bower JH, Yang P, Maraganore DM, McDonnell SK, Ahlskog JE, Rocca WA. Risk of cancer after the diagnosis of Parkinson\u2019s disease: a historical cohort study. Mov Disord. 2005;20:719\u201325.","journal-title":"Mov Disord"},{"key":"466_CR26","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10552-009-9497-6","volume":"21","author":"A Bajaj","year":"2010","unstructured":"Bajaj A, Driver JA, Schernhammer ES. Parkinson\u2019s disease and cancer risk: a systematic review and meta-analysis. Cancer Causes Control. 2010;21:697\u2013707.","journal-title":"Cancer Causes Control"},{"key":"466_CR27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn3464","volume":"14","author":"R Tabar\u00e9s-Seisdedos","year":"2013","unstructured":"Tabar\u00e9s-Seisdedos R, Rubenstein JL. Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nat Rev Neurosci. 2013;14:293\u2013304.","journal-title":"Nat Rev Neurosci"},{"key":"466_CR28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s10522-014-9523-2","volume":"15","author":"JA Driver","year":"2014","unstructured":"Driver JA. Inverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence. Biogerontology. 2014;15:547\u201357.","journal-title":"Biogerontology"},{"key":"466_CR29","doi-asserted-by":"crossref","first-page":"e1004173","DOI":"10.1371\/journal.pgen.1004173","volume":"10","author":"K Ib\u00e1\u00f1ez","year":"2014","unstructured":"Ib\u00e1\u00f1ez K, Boullosa C, Tabar\u00e9s-Seisdedos R, Baudot A, Valencia A. Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet. 2014;10:e1004173.","journal-title":"PLoS Genet"},{"key":"466_CR30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/jnci\/dji184","volume":"97","author":"PA Kyzas","year":"2005","unstructured":"Kyzas PA, Loizou KT, Ioannidis JP. Selective reporting biases in cancer prognostic factor studies. J Natl Cancer Inst. 2005;97:1043\u201355.","journal-title":"J Natl Cancer Inst"},{"key":"466_CR31","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1016\/j.ejca.2007.08.030","volume":"43","author":"PA Kyzas","year":"2007","unstructured":"Kyzas PA, Denaxa-Kyza D, Ioannidis JP. Almost all articles on cancer prognostic markers report statistically significant results. Eur J Cancer. 2007;43:2559\u201379.","journal-title":"Eur J Cancer"},{"key":"466_CR32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/jnci\/djs437","volume":"104","author":"KK Tsilidis","year":"2012","unstructured":"Tsilidis KK, Papatheodorou SI, Evangelou E, Ioannidis JP. Evaluation of excess statistical significance in meta-analyses of 98 biomarker associations with cancer risk. J Natl Cancer Inst. 2012;104:1867\u201378.","journal-title":"J Natl Cancer Inst"},{"key":"466_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/annonc\/mdt372","volume":"25","author":"JP Ioannidis","year":"2014","unstructured":"Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN. Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses. Ann Oncol. 2014;25:16\u201323.","journal-title":"Ann Oncol"},{"key":"466_CR34","doi-asserted-by":"crossref","first-page":"g7607","DOI":"10.1136\/bmj.g7607","volume":"350","author":"KK Tsilidis","year":"2015","unstructured":"Tsilidis KK, Kasimis JC, Lopez DS, Ntzani EE, Ioannidis JP. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ. 2015;350:g7607.","journal-title":"BMJ"},{"key":"466_CR35","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.comppsych.2014.05.007","volume":"55","author":"G Raviv","year":"2014","unstructured":"Raviv G, Laufer M, Baruch Y, Barak Y. Risk of prostate cancer in patients with schizophrenia. Compr Psychiatry. 2014;55:1639\u201342.","journal-title":"Compr Psychiatry"},{"key":"466_CR36","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.ejca.2014.06.018","volume":"50","author":"EL Ong","year":"2014","unstructured":"Ong EL, Goldacre R, Goldacre M. Differential risks of cancer types in people with Parkinson\u2019s disease: a national record-linkage study. Eur J Cancer. 2014;50:2456\u201362.","journal-title":"Eur J Cancer"},{"key":"466_CR37","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jpeds.2014.10.029","volume":"166","author":"HL Chiang","year":"2015","unstructured":"Chiang HL, Liu CJ, Hu YW, Chen SC, Hu LY, Shen CC, Yeh CM, Chen TJ, Gau SS. Risk of cancer in children, adolescents, and young adults with autistic disorder. J Pediatr. 2015;166:418\u201323.","journal-title":"J Pediatr"},{"issue":"12","key":"466_CR38","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiat. 2015;72(12):1172\u201381.","journal-title":"JAMA Psychiat"},{"key":"466_CR39","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamaoncol.2015.1752","volume":"1","author":"PY Lin","year":"2015","unstructured":"Lin PY, Chang SN, Hsiao TH, Huang BT, Lin CH, Yang PC. Association between Parkinson disease and risk of cancer in Taiwan. JAMA Oncol. 2015;1:633\u201340.","journal-title":"JAMA Oncol"},{"key":"466_CR40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/ane.12524","volume":"134","author":"CF Tang","year":"2016","unstructured":"Tang CF, Lu MK, Muo CH, Tsai CH, Kao CH. Increased risk of brain tumor in patients with Parkinson\u2019s disease: a nationwide cohort study in Taiwan. Acta Neurol Scand. 2016;134:148\u201353.","journal-title":"Acta Neurol Scand"},{"key":"466_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.","journal-title":"Syst Rev"},{"key":"466_CR42","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","volume":"349","author":"L Shamseer","year":"2015","unstructured":"Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.","journal-title":"BMJ"},{"key":"466_CR43","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1503\/cmaj.081086","volume":"181","author":"JP Ioannidis","year":"2009","unstructured":"Ioannidis JP. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181:488\u201393.","journal-title":"CMAJ"},{"key":"466_CR44","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","volume":"348","author":"E Theodoratou","year":"2014","unstructured":"Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014;348:g2035.","journal-title":"BMJ"},{"key":"466_CR45","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1474-4422(14)70267-4","volume":"14","author":"L Belbasis","year":"2015","unstructured":"Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol. 2015;14:263\u201373.","journal-title":"Lancet Neurol"},{"key":"466_CR46","doi-asserted-by":"publisher","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JP, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement. 2016 . doi: 10.1016\/j.jalz.2016.07.152 .","DOI":"10.1016\/j.jalz.2016.07.152"},{"key":"466_CR47","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","volume":"1","author":"C Fitzmaurice","year":"2015","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The global burden of cancer 2013. JAMA Oncol. 2015;1:505\u201327.","journal-title":"JAMA Oncol"},{"key":"466_CR48","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jclinepi.2007.10.003","volume":"61","author":"M Sampson","year":"2008","unstructured":"Sampson M, Shojania KG, McGowan J, Daniel R, Rader T, Iansavichene AE, et al. Surveillance search techniques identified the need to update systematic reviews. J Clin Epidemiol. 2008;61:755\u201362.","journal-title":"J Clin Epidemiol"},{"key":"466_CR49","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/2046-4053-2-44","volume":"2","author":"B Hutton","year":"2013","unstructured":"Hutton B, Tetzlaff J, Yazdi F, Thielman J, Kanji S, Fergusson D, et al. Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analyses. Syst Rev. 2013;2:44.","journal-title":"Syst Rev"},{"key":"466_CR50","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13643-015-0005-7","volume":"4","author":"F Catal\u00e1-L\u00f3pez","year":"2015","unstructured":"Catal\u00e1-L\u00f3pez F, Hutton B, N\u00fa\u00f1ez-Beltr\u00e1n A, Mayhew AD, Page MJ, Ridao M, et al. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials. Syst Rev. 2015;4:19.","journal-title":"Syst Rev"},{"key":"466_CR51","doi-asserted-by":"crossref","first-page":"e1001971","DOI":"10.1371\/journal.pmed.1001971","volume":"13","author":"F Catal\u00e1-L\u00f3pez","year":"2016","unstructured":"Catal\u00e1-L\u00f3pez F, Mac\u00edas Saint-Gerons D, Gonz\u00e1lez-Bermejo D, Rosano GM, Davis BR, Ridao M, et al. Cardiovascular and renal outcomes of renin-angiotensin system blockade in adult patients with diabetes mellitus: a systematic review with network meta-analyses. PLoS Med. 2016;13:e1001971.","journal-title":"PLoS Med"},{"key":"466_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","volume":"7","author":"BJ Shea","year":"2007","unstructured":"Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007;7:10.","journal-title":"BMC Med Res Methodol"},{"key":"466_CR53","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses; 2008. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp . Accessed 16 Oct 2016."},{"key":"466_CR54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2288-11-15","volume":"11","author":"V Smith","year":"2011","unstructured":"Smith V, Devane D, Begley CM, Clarke M. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011;11:15.","journal-title":"BMC Med Res Methodol"},{"key":"466_CR55","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"466_CR56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101\u201329.","journal-title":"Biometrics"},{"key":"466_CR57","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"466_CR58","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","volume":"172","author":"JP Higgins","year":"2009","unstructured":"Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172:137\u201359.","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"466_CR59","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","volume":"342","author":"RD Riley","year":"2011","unstructured":"Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011;342:d549.","journal-title":"BMJ"},{"key":"466_CR60","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","volume":"386","author":"MH Forouzanfar","year":"2015","unstructured":"GBD 2013 Risk Factors Collaborators, Forouzanfar MH, Alexander L, Anderson HR, Bachman VF, Biryukov S, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2015;386:2287\u2013323.","journal-title":"Lancet"},{"key":"466_CR61","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(16)31679-8","volume":"388","author":"GBD 2015 Risk Factors Collaborators","year":"2016","unstructured":"GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1659\u2013724.","journal-title":"Lancet"},{"key":"466_CR62","unstructured":"World Cancer Research Fund \/ American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. Washington, D.C: AICR, 2007. http:\/\/www.aicr.org\/assets\/docs\/pdf\/reports\/Second_Expert_Report.pdf ."},{"key":"466_CR63","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE Working Group: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336:924\u20136.","journal-title":"BMJ"},{"key":"466_CR64","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199207233270406","volume":"327","author":"J Lau","year":"1992","unstructured":"Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992;327:248\u201354.","journal-title":"N Engl J Med"},{"key":"466_CR65","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1073\/pnas.98.3.831","volume":"98","author":"J Ioannidis","year":"2001","unstructured":"Ioannidis J, Lau J. Evolution of treatment effects over time: empirical insight from recursive cumulative metaanalyses. Proc Natl Acad Sci U S A. 2001;98:831\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"466_CR66","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629\u201334.","journal-title":"BMJ"},{"key":"466_CR67","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088\u2013101.","journal-title":"Biometrics"},{"key":"466_CR68","volume-title":"Meta-analysis in Stata: an updated collection from the Stata Journal","year":"2016","unstructured":"Palmer TM, Sterne JAC, Newton HJ, Cox NJ, editors. Meta-analysis in Stata: an updated collection from the Stata Journal. 2nd ed. Texas: StataCorp LP; 2016.","edition":"2"},{"key":"466_CR69","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1136\/bmj.329.7471.868","volume":"329","author":"E Elm von","year":"2004","unstructured":"von Elm E, Egger M. The scandal of poor epidemiological research. BMJ. 2004;329:868\u20139.","journal-title":"BMJ"},{"key":"466_CR70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(13)62227-8","volume":"383","author":"JP Ioannidis","year":"2014","unstructured":"Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014;383:166\u201375.","journal-title":"Lancet"},{"key":"466_CR71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0140-6736(13)62228-X","volume":"383","author":"P Glasziou","year":"2014","unstructured":"Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, Julious S, et al. Reducing waste from incomplete or unusable reports of biomedical research. Lancet. 2014;383:267\u201376.","journal-title":"Lancet"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-017-0466-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:08:53Z","timestamp":1498385333000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-017-0466-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,4]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1186\/s13643-017-0466-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,4]]},"article-number":"69"}}